| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |